Rachel Pooley
Charles River Laboratories (United Kingdom)(GB)Ohio University(US)
Publications by Year
Research Areas
CRISPR and Genetic Engineering, Advanced biosensing and bioanalysis techniques, Monoclonal and Polyclonal Antibodies Research, DNA Repair Mechanisms, RNA and protein synthesis mechanisms
Most-Cited Works
- → Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens(2019)1,391 cited
- → Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting(2018)142 cited
- → Prioritisation of oncology therapeutic targets using CRISPR-Cas9 screening(2018)7 cited
- → Preliminary Experience With Quadratus Lumborum Catheters for Postoperative Pain Management in Pediatric-Aged Patients With Contraindications to Epidural Anesthesia(2022)4 cited
- → Abstract 3794: Developing an mRNA nanomedicine platform to democratise therapeutic antibodies(2025)2 cited
- → Abstract LB009: Safety profile assessment for IND-enabling studies: Bispecific antibodies and antibody-drug conjugates (ADCs)(2025)1 cited
- → Abstract 2714: Developing an mRNA encoded therapeutic antibody platform to simplify manufacturing and reduce time to clinic(2024)1 cited
- → PO-327 Whole-genome CRISPR-CAS9 screening: the wellcome sanger institute cellular generation and phenotyping pipeline(2018)
- → 42. Retrospective review of outcomes in patients with Bertolotti’s syndrome who underwent intra-articular pseudo-joint injection(2025)